Phenylacetylglutamine (sodium)
Phenylacetylglutamine (sodium) can be obtained from the hydrolysis of Antineoplaston A10. Phenylacetylglutamine (sodium) exhibits antineoplastic activity in breast carcinoma tissue culture. Phenylacetylglutamine (sodium) exerts low actue and chronic toxicity in mouse model. Phenylacetylglutamine (sodium) can be studied in research on breast cancer[1].
Product Specifications
CAS Number
[104771-87-1]
Product Name Alternative
NSC 203800 (sodium) ; Phenylacetyl-L-glutamine (sodium)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Biochemical Assay Reagents; Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Cancer
Smiles
O=C(CC1=CC=CC=C1)N[C@H](C(O[Na])=O)CCC(N)=O
Molecular Formula
C13H15N2NaO4
Molecular Weight
286.26
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Burzynski SR, et al., Preclinical studies on antineoplaston AS2-1 and antineoplaston AS2-5. Drugs Exp Clin Res. 1986;12 Suppl 1:11-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite; Microbial Metabolite
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human KNCN shRNA (UAS) - Lentiviral human KNCN shRNA (UAS, GFP) plasmid
